Other News

Capital Markets

Latham advises Cheplapharm on 390m note placement

Latham & Watkins advised Cheplapharm Arzneimittel on a private placement of 390 million senior secured notes, which refinances debt following its term loan B financing and its partnership with Sanofi.

Categories

SIGN UP TO OUR NEWSLETTER